MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Medicinova Inc market cap is $67.11M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medicinova Inc 52 week high is $3.90 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medicinova Inc 52 week low is $1.22 as of November 22, 2026.
Medicinova Inc stock price today is $1.31.
Medicinova Inc stock price yesterday was $1.27.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Medicinova Inc's P/E ratio is -6.12.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Medicinova Inc P/B ratio is 1.6332.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Medicinova Inc 50-day moving average is $1.74.